epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Addict Neurosci

1h

Addiction cravings ease after music therapy

In a pilot study, patients rated their craving as reduced right after sessions. . .

BMJ

6h

Menstrual apps promise health benefits without convincing evidence

Tracking may also prompt users to misread their symptoms and fixate on habits with no proven payoff, while the apps collect health data with little and varying regulation. . .

AAP 2026

1d

Guns in homes with young kids are more often unsecured

Parents who keep a firearm mostly cited protection as the reason, but loaded or unlocked storage was common. . .

Pediatrics

1d

Generative AI clinician tools need to be built for pediatrics

The American Academy of Pediatrics says models trained on adult data can miss how children grow and develop. . .

O&G Open

2d

Abortion bans may be reshaping early pregnancy care

Physicians describe narrower practice, more specialist referrals, training gaps, and mounting workforce strain in states with abortion bans. . .

Nat Med

2d

Urine RNA test detects 95% of localized bladder cancers

The approach outperformed existing urine tests, including cytology and a DNA-based assay, and may predict which patients will respond to treatment. . .

epocrates

2d

September 2026 FDA drug approvals at a glance

Cancer therapies guided by molecular testing and breakthroughs for rare diseases, plus new options for Parkinson’s and kidney disease.. . .

NEJM AI

2d

AI matches human readers on HPV-positive cervical triage

The AI system detected high-grade disease at rates equal to or better than manual dual-stain reading in every cohort, though it gave up some specificity in the largest one. . .

EASD 2026

2d

Fat-cell injection shrinks harmful belly fat in phase 2 study

MRI data suggest CBL-514 reduces visceral fat, a key driver of cardiometabolic disease, while early animal studies hint at improved weight maintenance after GLP-1 withdrawal. . .

Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information